Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/15/2023 | -33.7% | Barclays | → $6 | Initiates Coverage On | → Underweight |
11/03/2023 | -11.6% | Wedbush | $11 → $8 | Maintains | Neutral |
10/17/2023 | -0.55% | JP Morgan | $12 → $9 | Maintains | Neutral |
10/03/2023 | -0.55% | Goldman Sachs | $11 → $9 | Maintains | Neutral |
08/30/2023 | 16.02% | UBS | $8.5 → $10.5 | Maintains | Neutral |
08/15/2023 | 10.5% | Piper Sandler | $8 → $10 | Maintains | Neutral |
08/08/2023 | 21.55% | Wedbush | $8.5 → $11 | Maintains | Neutral |
08/07/2023 | — | Keefe, Bruyette & Woods | Upgrades | Underperform → Market Perform | |
08/04/2023 | -0.55% | Morgan Stanley | $7 → $9 | Maintains | Equal-Weight |
08/04/2023 | 10.5% | Goldman Sachs | $9 → $10 | Maintains | Neutral |
05/22/2023 | — | Argus Research | Upgrades | Sell → Hold | |
05/09/2023 | -22.65% | Keefe, Bruyette & Woods | $6 → $7 | Maintains | Underperform |
05/08/2023 | -11.6% | Piper Sandler | $7.5 → $8 | Maintains | Neutral |
05/08/2023 | -0.55% | RBC Capital | → $9 | Reiterates | → Sector Perform |
05/08/2023 | -6.08% | Wedbush | $8 → $8.5 | Maintains | Neutral |
05/05/2023 | -0.55% | Goldman Sachs | $8 → $9 | Maintains | Neutral |
05/05/2023 | -0.55% | Citigroup | $8 → $9 | Maintains | Neutral |
04/17/2023 | 4.97% | JP Morgan | $8 → $9.5 | Maintains | Neutral |
03/02/2023 | -11.6% | Goldman Sachs | $7 → $8 | Maintains | Neutral |
03/02/2023 | -22.65% | Credit Suisse | → $7 | Reiterates | → Underperform |
03/01/2023 | -11.6% | Citigroup | $7 → $8 | Maintains | Neutral |
12/06/2022 | 10.5% | Wells Fargo | $7 → $10 | Maintains | Overweight |
11/16/2022 | — | Argus Research | Downgrades | Hold → Sell | |
11/07/2022 | -28.18% | Goldman Sachs | $7.25 → $6.5 | Maintains | Neutral |
11/04/2022 | -22.65% | Wells Fargo | $10 → $7 | Maintains | Overweight |
11/04/2022 | -28.18% | Morgan Stanley | $7 → $6.5 | Maintains | Equal-Weight |
10/18/2022 | -11.6% | JP Morgan | $8.5 → $8 | Maintains | Neutral |
10/17/2022 | -44.75% | Barclays | $7 → $5 | Maintains | Equal-Weight |
10/04/2022 | -19.89% | Goldman Sachs | $8.25 → $7.25 | Maintains | Neutral |
09/30/2022 | -11.6% | Piper Sandler | $9 → $8 | Maintains | Neutral |
09/06/2022 | -6.08% | JP Morgan | $11 → $8.5 | Downgrades | Overweight → Neutral |
08/08/2022 | -28.18% | Keefe, Bruyette & Woods | → $6.5 | Downgrades | Market Perform → Underperform |
08/08/2022 | 10.5% | RBC Capital | $9 → $10 | Maintains | Sector Perform |
07/11/2022 | -11.6% | Barclays | $11 → $8 | Maintains | Equal-Weight |
07/06/2022 | 10.5% | Wells Fargo | → $10 | Upgrades | Equal-Weight → Overweight |
06/17/2022 | -28.18% | Wells Fargo | $8 → $6.5 | Maintains | Equal-Weight |
05/16/2022 | -22.65% | Keefe, Bruyette & Woods | $10 → $7 | Upgrades | Underperform → Market Perform |
05/12/2022 | -0.55% | Goldman Sachs | $11.5 → $9 | Maintains | Neutral |
05/12/2022 | -0.55% | RBC Capital | $18 → $9 | Maintains | Sector Perform |
05/11/2022 | -22.65% | Morgan Stanley | $11 → $7 | Maintains | Equal-Weight |
05/11/2022 | -11.6% | Citigroup | $14 → $8 | Downgrades | Buy → Neutral |
05/11/2022 | -11.6% | Wells Fargo | $13 → $8 | Maintains | Equal-Weight |
04/12/2022 | 43.65% | Barclays | $14 → $13 | Maintains | Equal-Weight |
04/07/2022 | 21.55% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
04/04/2022 | 27.07% | Goldman Sachs | $14 → $11.5 | Maintains | Neutral |
02/28/2022 | 54.7% | Barclays | $19 → $14 | Maintains | Equal-Weight |
02/28/2022 | 54.7% | Citigroup | $23 → $14 | Maintains | Buy |
02/25/2022 | 43.65% | Credit Suisse | $16 → $13 | Maintains | Neutral |
01/19/2022 | 65.75% | JP Morgan | $17.5 → $15 | Upgrades | Underweight → Overweight |
12/16/2021 | 87.85% | Wells Fargo | $20 → $17 | Maintains | Equal-Weight |
11/30/2021 | 65.75% | Morgan Stanley | $19 → $15 | Maintains | Equal-Weight |
10/11/2021 | 98.9% | Barclays | $19 → $18 | Maintains | Equal-Weight |
10/08/2021 | 132.05% | RBC Capital | $24 → $21 | Maintains | Sector Perform |
08/13/2021 | 165.2% | RBC Capital | $26 → $24 | Maintains | Sector Perform |
08/13/2021 | 109.95% | Barclays | $20 → $19 | Maintains | Equal-Weight |
08/13/2021 | 109.95% | Morgan Stanley | $18 → $19 | Maintains | Equal-Weight |
08/13/2021 | 109.95% | Credit Suisse | $18 → $19 | Maintains | Neutral |
07/20/2021 | 32.6% | Wedbush | → $12 | Downgrades | Neutral → Underperform |
07/12/2021 | 98.9% | Jefferies | $26 → $18 | Downgrades | Buy → Hold |
07/09/2021 | 121% | Barclays | $21 → $20 | Maintains | Equal-Weight |
06/08/2021 | 154.15% | Argus Research | → $23 | Initiates Coverage On | → Buy |
06/08/2021 | 98.9% | Piper Sandler | → $18 | Initiates Coverage On | → Neutral |
05/28/2021 | 98.9% | Morgan Stanley | $24 → $18 | Maintains | Equal-Weight |
05/07/2021 | 104.42% | Goldman Sachs | $23 → $18.5 | Maintains | Neutral |
05/06/2021 | 137.57% | Credit Suisse | $23 → $21.5 | Maintains | Neutral |
04/21/2021 | 165.2% | B of A Securities | $27 → $24 | Downgrades | Buy → Neutral |
03/09/2021 | 165.2% | Morgan Stanley | $23 → $24 | Maintains | Equal-Weight |
03/03/2021 | 231.5% | RBC Capital | → $30 | Downgrades | Outperform → Sector Perform |
01/19/2021 | 121% | JP Morgan | → $20 | Downgrades | Overweight → Underweight |
12/18/2020 | 109.95% | Keefe, Bruyette & Woods | → $19 | Downgrades | Market Perform → Underperform |
11/11/2020 | 198.35% | B of A Securities | $32 → $27 | Reiterates | → Buy |
11/11/2020 | 198.35% | Credit Suisse | $29 → $27 | Maintains | Neutral |
11/02/2020 | 154.15% | Morgan Stanley | $25 → $23 | Maintains | Equal-Weight |
10/09/2020 | 214.92% | JP Morgan | → $28.5 | Upgrades | Neutral → Overweight |
09/25/2020 | 121% | Susquehanna | → $20 | Upgrades | Negative → Neutral |
09/10/2020 | 165.2% | Wedbush | → $24 | Initiates Coverage On | → Neutral |
09/08/2020 | 121% | Susquehanna | $18 → $20 | Downgrades | Neutral → Negative |
08/31/2020 | 220.45% | Credit Suisse | → $29 | Initiates Coverage On | → Neutral |
08/31/2020 | 176.25% | Barclays | → $25 | Initiates Coverage On | → Equal-Weight |
08/31/2020 | 253.6% | B of A Securities | → $32 | Initiates Coverage On | → Buy |
08/31/2020 | 286.74% | Citigroup | → $35 | Initiates Coverage On | → Buy |
08/31/2020 | 176.25% | Morgan Stanley | → $25 | Initiates Coverage On | → Equal-Weight |
08/31/2020 | 253.6% | RBC Capital | → $32 | Initiates Coverage On | → Outperform |
08/31/2020 | 220.45% | Wells Fargo | → $29 | Initiates Coverage On | → Equal-Weight |
08/13/2020 | 98.9% | Susquehanna | → $18 | Initiates Coverage On | → Neutral |
What is the target price for Rocket Companies (RKT)?
The latest price target for Rocket Companies (NYSE: RKT) was reported by Barclays on November 15, 2023. The analyst firm set a price target for $6.00 expecting RKT to fall to within 12 months (a possible -33.70% downside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Rocket Companies (RKT)?
The latest analyst rating for Rocket Companies (NYSE: RKT) was provided by Barclays, and Rocket Companies initiated their underweight rating.
When is the next analyst rating going to be posted or updated for Rocket Companies (RKT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rocket Companies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rocket Companies was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.
Is the Analyst Rating Rocket Companies (RKT) correct?
While ratings are subjective and will change, the latest Rocket Companies (RKT) rating was a initiated with a price target of $0.00 to $6.00. The current price Rocket Companies (RKT) is trading at is $9.05, which is out of the analyst's predicted range.